Frederiksberg, Denmark

Michael John O'Reilly

This inventor holds 1 USPTO granted patent. Top assignee: Novozymes A/s. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael John O'Reilly: Innovator in Glycosidase and Peptidase Recovery

Introduction

Michael John O'Reilly is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of biochemistry, particularly in the recovery of enzymes from culture solutions. His innovative approach has implications for various applications in biotechnology.

Latest Patents

O'Reilly holds a patent for the invention titled "Recovery of a glycosidase or peptidase from a culture broth at high pH." This patent describes a method for recovering a glycosidase or peptidase from a culture solution, transitioning it from an unsolubilized state to a solubilized state within the solution. This advancement is crucial for enhancing the efficiency of enzyme recovery processes.

Career Highlights

Michael John O'Reilly is associated with Novozymes A/S, a leading company in the biotechnology sector. His work at Novozymes focuses on enzyme technology, contributing to the development of sustainable solutions for various industries. O'Reilly's expertise in enzyme recovery has positioned him as a valuable asset in his field.

Collaborations

O'Reilly has collaborated with notable colleagues, including Mads Aage Laustsen and Curran Matthew Simpson. These partnerships have fostered innovation and have been instrumental in advancing research in enzyme recovery and application.

Conclusion

Michael John O'Reilly's contributions to the field of biochemistry, particularly through his patent on enzyme recovery, highlight his role as an innovator in biotechnology. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…